← All trials
NCT05928468
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 25, 2023
- Primary completion
- Jul 31, 2023
- Completion date
- Nov 30, 2023
- First posted
- Jul 3, 2023
- Last posted
- Jul 3, 2023
- Enrollment
- 210
- Arms / groups
- 3 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Government of ChinaLead sponsor
- North Sichuan Medical UniversityCollaborator
- Government of ChinaCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.